Key result
Mechanical thrombectomy plus bridging tPA proves cost-effective in acute stroke at ~$12,000 per QALY gained.
Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: Recently, 5 randomized controlled trials demonstrated the benefit of endovascular therapy compared with intravenous tissue-type plasminogen activator in acute stroke. Economic evidence evaluating stent retrievers is limited. We compared the cost-effectiveness of intravenous tissue-type plasminogen activator alone versus mechanical thrombectomy and intravenous tissue-type plasminogen activator as a bridging therapy in eligible patients in the UK National Health Service. METHODS: A model-based cost-utility analysis was performed using a lifetime horizon. A Markov model was constructed and populated with probabilities, outcomes, and cost data from published sources, including 1-way and probabilistic sensitivity analysis. RESULTS: Mechanical thrombectomy was more expensive than intravenous tissue-type plasminogen activator, but it improved quality-adjusted life expectancy. The incremental cost per (quality-adjusted life year) gained of mechanical thrombectomy over a 20 year period was $11 651 (£7061). The probabilistic sensitivity analysis demonstrated that thrombectomy had a 100% probability of being cost-effective at the minimum willingness to pay for a quality-adjusted life year commonly used in United Kingdom. CONCLUSIONS: Although the upfront costs of thrombectomy are high, the potential quality-adjusted life year gains mean this intervention is cost-effective. This is an important factor for consideration in deciding whether to commission this intervention.
No takes yet. Share an insight, caveat, or question.
Ganesalingam et al. (2015) studied Acute ischemic stroke. Mechanical thrombectomy using stent retrievers with bridging intravenous tissue-type plasminogen activator vs. Intravenous tissue-type plasminogen activator alone was evaluated on Incremental cost per quality-adjusted life year (QALY) gained (ICER $11,651 (£7,061) per QALY gained). Mechanical thrombectomy with bridging IV tPA was cost-effective versus IV tPA alone in acute stroke, yielding an ICER of $11,651 (£7,061) per QALY gained over 20 years.
Synapse has enriched 10 related papers. Consider them for comparative context: